November 30, 2024 - 19:08

A. Cornelius Baker, a prominent figure in the fight for H.I.V. testing and the rights of individuals affected by H.I.V. and AIDS, has died at the age of 63. Throughout his career, Baker worked tirelessly both within government agencies and as an advocate in the community, focusing on improving the lives of those impacted by the epidemic, particularly among minority populations.
Baker's commitment to public health and social justice was evident in his efforts to increase awareness and access to H.I.V. testing. He believed that education and outreach were crucial in combating the stigma surrounding H.I.V. and AIDS, especially in marginalized communities. His advocacy work helped to shape policies that aimed to provide better healthcare resources and support for individuals living with the virus.
His legacy will be remembered not only for his professional achievements but also for the compassion and dedication he showed to those he served. Baker's passing marks a significant loss in the ongoing struggle for health equity and the rights of people living with H.I.V. and AIDS.
June 10, 2026 - 01:12
Why AI Is Creating New Cybersecurity Risks For HealthcareArtificial intelligence is transforming how hospitals diagnose disease, manage patient records, and even predict treatment outcomes. But the same technology that speeds up medical breakthroughs is...
June 9, 2026 - 03:31
SGMC Health Welcomes Neonatologist Josef Cortez, MDSGMC Health has welcomed Dr. Josef Cortez, a board-certified neonatologist, to its medical staff as part of an effort to strengthen and broaden access to specialized care for newborns. Dr. Cortez...
June 8, 2026 - 04:03
Big money is pouring into South Florida health systems. What it means for patientsA wave of massive philanthropic gifts is transforming South Florida`s healthcare landscape, with wealthy donors funneling hundreds of millions of dollars into the region`s major hospital systems....
June 7, 2026 - 01:53
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair ValueThe narrative around Phibro Animal Health is shifting, and analysts have adjusted their numbers to reflect it. The latest update trims the assessed fair value for the stock from US$48.50 down to US...